Kits Eyecare Ltd.
TSX:KITS.TOSpecialty Retail
-$0.18 today
- Market cap
- $650.54M
- Beta
- 0.20
- P/E (TTM)
- 126.0
- EPS (TTM)
- $0.10
Volume 0.08M
Average 0.14M
KITS.TO Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Kits Eyecare Ltd.TSX: KITS.TO
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 9.1% from a year ago
Common stock stood at CA$86.96M at the end of Q1 FY2026, up 9.1% from a year earlier and up 6.3% from the prior quarter. Over 3 fiscal years it compounded at +2.0% a year.
Context
- Common stock amounted to 80.9% of total assets at the end of Q1 FY2026, up 2.1 pp from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +9.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
CAD · from the balance sheet
- Latest · FY2025
- 81.77M CAD
- Year-over-year change
- +4.6%
- 4-year CAGR
- +1.6%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.77M | +4.6% |
| FY2024 | 2024-12-31 | 78.16M | +1.0% |
| FY2023 | 2023-12-31 | 77.39M | +0.5% |
| FY2022 | 2022-12-31 | 76.99M | +0.5% |
| FY2021 | 2021-12-31 | 76.59M | — |
Common Stock vs competitors
How KITS.TO compares with its peers on the latest reported figures
- KITS.TO's Mar 2026 common stock of CA$86.96M is the 7th highest of the 10 companies compared; the peer median is CA$135.9M.
- Its year-over-year change of +9.1% is the 2nd highest of 10, against a peer median of -1.6%.
- Common stock amounts to 80.9% of total assets for KITS.TO, versus a peer median of 14.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$426.15M | +0.0% | -0.6% | 14.9% | |
| Mar 2026 | CA$347.47M | +43.6% | +12.1% | 90.9% | |
| Apr 2026 | CA$182.09M | -1.8% | -1.3% | 62.1% | |
| Mar 2026 | CA$152.2M | +0.0% | +0.5% | 22.0% | |
| Mar 2026 | CA$135.9M | -1.9% | -3.5% | 77.7% | |
| Mar 2026 | CA$101.4M | -0.6% | -0.3% | 13.3% | |
| Mar 2026 | CA$86.96M | +9.1% | +2.0% | 80.9% | |
| Mar 2026 | CA$76.71M | -6.7% | -1.1% | 11.6% | |
| Mar 2026 | CA$47.12M | -2.1% | -0.8% | 7.6% | |
| Apr 2026 | CA$2.52M | -1.6% | -1.2% | 0.3% | |
| Peer median (excluding KITS.TO) | CA$135.9M | -1.6% | -0.8% | 14.9% | |
Competitors are the stored peer set for KITS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20.51M | 18.79M | 16.04M | 19.27M | 29.82M |
| Short-term Investments | 0 | 0 | 0 | 0 | 3.86M |
| Net Receivables | 861K | 917K | 1.8M | 2.53M | 2.36M |
| Inventory | 13.49M | 16.41M | 15.41M | 22.49M | 23.67M |
| Other Current Assets | 0 | 0 | 728K | 787K | 980K |
| Total Current Assets | 35.71M | 37M | 33.98M | 45.08M | 60.69M |
| Property, Plant & Equipment (Net) | 10.93M | 10.04M | 8.65M | 10.86M | 9.12M |
| Goodwill | 36.29M | 38.77M | 37.86M | 41.19M | 39.23M |
| Intangible Assets | 4.46M | 2.94M | 1.47M | 1.15M | 1.13M |
| Long-term Investments | (3.55M) | (5.12M) | 0 | 0 | 0 |
| Tax Assets | 3.55M | 5.12M | 5.68M | 4.76M | 2.65M |
| Other Non-current Assets | 3.55M | 5.12M | 5.68M | 4.76M | 134K |
| Total Non-current Assets | 55.23M | 56.87M | 53.66M | 57.95M | 52.27M |
| Total Assets | 90.94M | 93.87M | 87.64M | 103.02M | 112.96M |
| Account Payables | 8.36M | 14.47M | 12.89M | 21.83M | 22.22M |
| Short-term Debt | 3.05M | 3.1M | 3.03M | 5.38M | 10.28M |
| Tax Payables | 395K | 422K | 412K | 448K | 0 |
| Deferred Revenue | 2.53M | 3.49M | 4.43M | 6.83M | 7.35M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 16.82M | 24.44M | 24.52M | 38.75M | 45.37M |
| Long-term Debt | 13.04M | 10.04M | 6.69M | 1.78M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 553K |
| Total Non-current Liabilities | 19.34M | 15.72M | 11.67M | 6.38M | 5.27M |
| Total Liabilities | 36.16M | 40.16M | 36.2M | 45.13M | 50.65M |
| Common Stock | 76.59M | 76.99M | 77.39M | 78.16M | 81.77M |
| Retained Earnings | (21.15M) | (25.7M) | (27.91M) | (24.8M) | (21.69M) |
| Accumulated OCI | (2.6M) | (440K) | (1.07M) | 1.4M | (216K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 54.79M | 53.71M | 51.45M | 57.89M | 62.31M |
| Total Debt | 22.94M | 19.44M | 15.39M | 12.6M | 15.82M |
| Net Debt | 2.44M | 648K | (646K) | (6.67M) | (13.99M) |
Kits Eyecare Ltd.
TSX:KITS.TO
Intrinsic Alpha fair value
Locked
Current Price
$19.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.